FDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant Pathogens
Bioiberica Receives Frost & Sullivan’s 2025 European New Product Innovation Award for Clinically Validated Native Type II Collagen
